3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lymphoid Interstitial Pneumonia
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Clinical Stage I Gastric Cancer AJCC v8
1
Cholangiocarcinoma
1
Interventions
fludarabine
9
Cyclophosphamide
8
fludarabine phosphate
7
Specimen Handling
7
Cytarabine
7
Biopsy
7
venetoclax
6
Whole-Body Irradiation
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Injections
5
decitabine and cedazuridine drug combination
4
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Cyclosporine
4
CPX-351
4
X-Rays
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
treosulfan
2
ruxolitinib
2
luspatercept
2
ivosidenib
2
gilteritinib
2
Sirolimus
2
Photons
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
dehydroftorafur
×
30 days
×
Clear all
No trials found.